Why the study?
What are the risk factors for severe over-anticoagulation (INR >7.0) in patients receiving long-term warfarin?
What are the risk factors for severe over-anticoagulation (INR >7.0) in patients receiving long-term warfarin?
Patients on long-term warfarin with a target INR of 3.5 or recent antibiotic use are at high risk for severe over-anticoagulation and bleeding, warranting intensified monitoring.
Answers are grounded in this paper and cite their sources.
May inform monitoring intensity in long-term warfarin users; hypothesis-generating for targeted prevention strategies.
A cohort of patients with an INR >7.0 were identified prospectively and compared with a group of patients with stable anticoagulant control. During the study 15,100 INR measurements were recorded and 31 (0.2%) were >7.0. Odds ratios of patient characteristics were calculated as an estimate of relative risk for the development of a high INR. The highest risk factor was a target INR of 3.5 (OR 7.3, 95% CI 2.6-20.2). The second highest risk factor was antibiotic therapy in the 4 weeks preceding the high INR (OR 6.2, 95% CI 1.4-27.7). Bleeding was reported more frequently in the high INR group (OR 5.4, 95% CI 2.1-13.9). Five major bleeds occurred in this group compared to none in the stable group. This analysis identifies risk factors for over-anticoagulation and hence when to intensify monitoring and when to consider pre-emptive warfarin dose reductions.
No takes yet. Share an insight, caveat, or question.
Panneerselvam et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: